Prognostic Significance of Residual Disease in Patients with Stage IV Epithelial Ovarian Cancer

By Munkarah A.R.   Hallum A.V.   Morris M.   Burke T.W.   Levenback C.   Atkinson E.N.   Wharton J.T.   Gershenson D.M.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 13-17

Elsevier

Access to resources Recommend Favorite

Optimal Cytoreductive Surgery Is an Independent Prognostic Indicator in Stage IV Epithelial Ovarian Cancer with Hepatic Metastases

By Naik R.   Nordin A.   Cross P.A.   Hemming D.   de Barros Lopes A.   Monaghan J.M.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 171-175

Elsevier

Access to resources Recommend Favorite

Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer

By Bristow R.E.   Montz F.J.   Lagasse L.D.   Leuchter R.S.   Karlan B.Y.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 278-287

Elsevier

Access to resources Recommend Favorite

Long-Term Results and Prognostic Factors in Patients with Epithelial Ovarian Cancer

By Brun J.-L.   Feyler A.   Chene G.   Saurel J.   Brun G.   Hocke C.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 21-27

Elsevier

Access to resources Recommend Favorite

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)

By Juan O.   Lluch A.   Paz L.d.   Prósper F.   Azagra P.   Marugán I.   Martínez-agulló A.   Garcia-conde J.  

Breast Cancer Research and Treatment, Vol. 53, Iss. 2, 1999-01 ,pp. : 105-112

Springer Publishing Company

Access to resources Recommend Favorite